Clinical Trials Sponsored by Innovive Pharmaceuticals

Total 19941 results

Innovive Pharmaceuticals

Terminated

INNO-105 in Patients With Solid Tumors

Tumors

United States
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Active, not recruiting

Study Impact on Outcome of Eltrombopag in Elderly Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy (EPAG2015)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Terminated

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Essential Thrombocythemia

France
Novartis Pharmaceuticals
Innovative Medicines Initiative

Withdrawn

Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD. (PROactive)

COPD
Novartis Pharmaceuticals
Innovative Medicines Initiative

Terminated

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis

Bronchiectasis

Germany, Spain, United Kingdom, China
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Completed

Phase I Study in RAD 001 Patients With Relapse AML

AML

France
H. Lee Moffitt Cancer Center and Research Institute
Innovive Pharmaceuticals

Completed

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Leukemia

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Innovive Pharmaceuticals

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Myelodysplastic Syndromes | Leukemia | Lung Cancer | Malignant Mesothelioma | Primary Peritoneal Cavity Cancer

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Nantes University Hospital
Chugai Pharmaceutical; French Innovative Leukemia Organisation

Completed

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk (LAM2006IR)

Acute Myeloid Leukemia

France
Innovative Neurotronics

Completed

WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients

Stroke

United States
Innovative Medical

Unknown

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Dry Eye Syndromes

United States
Innovative Medical

Completed

An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients

Myopia

United States
Innovative Medical

Completed

A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens

Dry Eye

United States
Innovative Medical

Completed

Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses

Aphakia

United States
Innovative Medical

Unknown

Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery

Cataracts

United States
Innovative Medical

Completed

An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses

Pseudophakia

United States
Innovative Medical

Completed

Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses

Cataract

United States
Innovative Medical

Completed

Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms

Dry Eye

United States
Innovative Medical

Completed

Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms

Dry Eye

United States
Innovative Medical

Completed

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

Scars

United States
Innovative Medical

Completed

Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients

Patient Comfort | Lens Cleanliness

United States
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects

Cataract

United States
Innovative Medical

Completed

Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

Corneal Staining

United States
Innovative Medical

Completed

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

Tear Film Thickness

United States
Innovative Medical

Completed

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

Corneal Staining

United States
Innovative Medical

Completed

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients

Cataract

United States
Innovative Medical

Completed

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Cataract

United States
Innovative Medical

Completed

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Glaucoma

United States
Innovative Medical

Completed

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Glaucoma

United States
Innovative Medical

Unknown

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

Pseudophakia | Cataract Surgery

United States
Innovative Medical

Unknown

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

Dry Eye

United States
Innovative Medical

Completed

Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery

Cataracts

United States
Innovative Medical

Completed

Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

Astigmatism | Cataracts

United States
Innovative Medical

Completed

Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions

Cataracts

United States
Innovative Medical

Completed

Laser Cataract Surgery With the Femtosecond Laser Technology

Cataracts

United States
Innovative Medical

Completed

Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence

Visual Acuity

United States
Innovative Medical

Completed

Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

Treatment of Dry Eye Disease

United States
Innovative Medical

Completed

Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy

Dry Eye Syndromes

United States
Innovative Medical

Completed

Topical Cyclosporine and Disease Progression

Disease Progression | Disease Severity | Staining | Schirmers | OSDI

United States
Innovative Medical

Completed

Refractive Surgery and Optive Compatibility Study

Dry Eye Syndromes

United States
Innovative Medical

Completed

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes

Dry Eye

United States
Innovative Medical

Terminated

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Skin Aging

United States
Innovative Medical

Completed

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Dry Eye

United States
Innovative Medical

Completed

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Glaucoma

United States
Innovative Medical

Completed

Ketorolac vs. Steroid in the Prevention of CME

Cataract

United States
Innovative Neurotronics

Completed

Efficacy of the WalkAide and AFOs for CVA

Stroke

United States
Innovative Medical

Completed

Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)

To Collect Information About Visual Outcomes and Participant Satisfaction

United States

3

Subscribe